Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

174.30 +3.68 (+2.16%)
Streaming Delayed Price Updated: 10:12 AM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
In a move that has sent shockwaves through both the pharmaceutical and technology sectors, Eli Lilly and Company (NYSE: LLY) announced today, April 6, 2026, the finalized acquisition of Contessa, a... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
News headline image
3 Profitable Stocks with Questionable Fundamentals
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗
Via Chartmill
News headline image
3 Value Stocks We Steer Clear Of
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t... 
Via StockStory
News headline image
3 Mid-Cap Stocks We Keep Off Our Radar
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
From IQVIA Holdings Inc.
Via Business Wire
News headline image
1 S&P 500 Stock Worth Your Attention and 2 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
Veeva Systems (VEEV) Surges 11%: Navigating the Vault CRM Migration and the Future of Life Sciences Software
On March 5, 2026, Veeva Systems Inc. (NYSE: VEEV) reminded the market why it remains the undisputed heavyweight of life sciences software. Following a blockbuster Q4 fiscal year 2026 earnings report... 
Via Finterra
Topics Artificial Intelligence Economy
News headline image
Veeva Systems Q4 FY2026 Results: Dominating the 'Sensitive' Tech Frontier
As the sun sets on the final quarter of the 2026 fiscal year, Veeva Systems (NYSE: VEEV) has once again proven its mettle in the volatile world of vertical software. Reporting its Q4 results on March... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference
From IQVIA
Via Business Wire
News headline image
IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Releases its 2025 Sustainability Report
From IQVIA
Via Business Wire
News headline image
3 Reasons to Sell IQV and 1 Stock to Buy Instead
Over the last six months, IQVIA’s shares have sunk to $163.04, producing a disappointing 13.2% loss - a stark contrast to the S&P 500’s 6.5% gain. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks
News headline image
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
From IQVIA
Via Business Wire
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but... 
Via StockStory
Topics Stocks
News headline image
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
The Clinical Crisis: A Deep-Dive Into ICON plc (ICLR) Amidst a Transformational Storm
Date: February 12, 2026 Introduction ICON plc (NASDAQ: ICLR) currently finds itself at a pivotal and precarious crossroads. As the world’s second-largest Clinical Research Organization (CRO), the... 
Via Finterra
Topics Artificial Intelligence Fraud Lawsuit
Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗
Via Chartmill
News headline image
The Top 5 Analyst Questions From IQVIA’s Q4 Earnings Call
IQVIA’s fourth quarter was marked by solid top-line growth, surpassing Wall Street’s revenue expectations. However, the market reacted negatively, focusing on margin compression and concerns about the... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions
From IQVIA
Via Business Wire
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
News headline image
IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis
Clinical research company IQVIA (NYSE: IQV) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.3% year on year to $4.36 billion. The company’s full-year revenue... 
Via StockStory
Topics Artificial Intelligence
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗
Via Chartmill
News headline image
IQVIA (IQV) Q4 2025 Earnings Call Transcript ↗
IQVIA (IQV) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
IQVIA (IQV) Stock Trades Down, Here Is Why
Shares of clinical research company IQVIA (NYSE: IQV) fell 8.5% in the morning session after the company issued a weak full-year 2026 profit forecast that fell below Wall Street expectations. 
Via StockStory
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.